We came across a bullish thesis on Alvotech on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on ALVO. Alvotech's share was trading at $4.60 as of December 2nd. ALVO’s trailing and forward P/E were 21.04 and 10.02 respectively according to Yahoo Finance. microscope, health Likoper/Shutterstock.com Alvotech is positioning itself as the “TSMC of biologics”—a fully integrated, globally compliant biosimilar manufacturer built around process control, regulatory trust, and sc ...